NM_014141.6:c.98-16942G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014141.6(CNTNAP2):c.98-16942G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.388 in 151,852 control chromosomes in the GnomAD database, including 13,146 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.39 ( 13146 hom., cov: 32)
Consequence
CNTNAP2
NM_014141.6 intron
NM_014141.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.68
Publications
3 publications found
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
- cortical dysplasia-focal epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.614 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CNTNAP2 | NM_014141.6 | c.98-16942G>A | intron_variant | Intron 1 of 23 | ENST00000361727.8 | NP_054860.1 | ||
| CNTNAP2 | XM_017011950.3 | c.98-16942G>A | intron_variant | Intron 1 of 13 | XP_016867439.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CNTNAP2 | ENST00000361727.8 | c.98-16942G>A | intron_variant | Intron 1 of 23 | 1 | NM_014141.6 | ENSP00000354778.3 | |||
| CNTNAP2 | ENST00000625365.2 | c.98-16942G>A | intron_variant | Intron 2 of 3 | 5 | ENSP00000485955.1 | ||||
| CNTNAP2 | ENST00000637150.1 | n.27-16942G>A | intron_variant | Intron 1 of 8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.387 AC: 58758AN: 151734Hom.: 13118 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
58758
AN:
151734
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.388 AC: 58843AN: 151852Hom.: 13146 Cov.: 32 AF XY: 0.388 AC XY: 28752AN XY: 74194 show subpopulations
GnomAD4 genome
AF:
AC:
58843
AN:
151852
Hom.:
Cov.:
32
AF XY:
AC XY:
28752
AN XY:
74194
show subpopulations
African (AFR)
AF:
AC:
25729
AN:
41456
American (AMR)
AF:
AC:
4045
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
1199
AN:
3470
East Asian (EAS)
AF:
AC:
2024
AN:
5156
South Asian (SAS)
AF:
AC:
1692
AN:
4812
European-Finnish (FIN)
AF:
AC:
4099
AN:
10510
Middle Eastern (MID)
AF:
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18935
AN:
67880
Other (OTH)
AF:
AC:
795
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1683
3366
5048
6731
8414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
530
1060
1590
2120
2650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1265
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.